Apravet 100 000 IU/g Premix for Medicated Feeding Stuff for Pigs and Rabbits

Ország: Egyesült Királyság

Nyelv: angol

Forrás: VMD (Veterinary Medicines Directorate)

Aktív összetevők:

Apramycin

Beszerezhető a:

Huvepharma N.V.

ATC-kód:

QA07AA92

INN (nemzetközi neve):

Apramycin

Gyógyszerészeti forma:

Premix for medicated feeding stuff

Recept típusa:

POM-V - Prescription Only Medicine – Veterinarian

Terápiás csoport:

Pigs, Rabbits

Terápiás terület:

Antimicrobial

Engedélyezési státusz:

Authorized

Engedély dátuma:

2017-02-02

Termékjellemzők

Revised: October 2021
AN: 02097/2020 & 02098/2020
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Apravet 100 000 IU/g premix for medicated feeding stuff for pigs and
rabbits
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
Active Substance:
Apramycin
100 000 IU – international units
(as apramycin sulphate)
Excipients:
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Premix for medicated feeding stuff
Light brown granules
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs and rabbits
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs:
Treatment and metaphylaxis of bacterial enteritis caused by
micro-organisms
susceptible to apramycin such as_ Escherichia coli_.
Rabbits:
Reduction in mortality and clinical signs related to epizootic
enterocolitis due to
_Escherichia Coli._
In the case of metaphylaxis, the presence of the disease in the group
must be
established before the product is used.
4.3
CONTRAINDICATIONS
Do not use in the cases of hypersensitivity to the active substance or
any of the
excipients.
Do not use in cats.
Revised: October 2021
AN: 02097/2020 & 02098/2020
Page 2 of 5
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The uptake of medication by animals can be altered as a consequence of
illness. In
case of insufficient uptake of feed animals should be treated
parenterally.
The use of the product should be combined with good management
practices e.g.
good hygiene, proper ventilation, no overstocking.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Use of the product should be based on susceptibility testing.
Official, national and
regional antimicrobial policies should be taken into account when the
veterinary
medicinal product is used.
Use of the product deviating from the instructions given in the SPC
may increase the
prevalence of bacteria resistant to the apramycin and may decrease the
effectiveness of treatment with aminoglycosides due to the potential
for cross
resistance
Special precautions